Taste and Smell Impairment in Critically Ill COVID-19 Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04532632

Enrollment

Registered

2020-08-31

Start date

2020-09-01

Completion date

2020-10-09

Last updated

2020-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus Infection, Smell Disorder, Taste Disorders

Keywords

Coronavirus disease-19, anosmia, hyposmia, dysgeusia

Brief summary

Evaluating the smell and taste perceptions of patients hospitalized in the intensive care unit with suspicion of Coronavirus disease-19 diagnosis with a survey study

Detailed description

Patients who were treated in the intensive care unit of Şişli Hamidiye Etfal Training and Research Hospital with the diagnosis of Coronavirus disease-19 will be determined by scanning the hospital registry system. It was planned that patients discharged from the intensive care unit would be called by phone and their complaints about smell and taste disorders were evaluated with a questionnaire.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Adults between the ages of 18-80 * Agree to participate in the study * Patients treated in the intensive care unit with the diagnosis of Coronavirus disease-19

Exclusion criteria

* Pre-existing smell and taste impairment * The patients have no enough cooperation to answer the questionnaire * Having additional diseases such as dementia and Alzheimer

Design outcomes

Primary

Measure	Time frame	Description
taste and smell impairment	up to 3 months	incidence of taste and smell impairment in critically ill subjects

Countries

Turkey (Türkiye)

Outcome results